GlobalData tracks 76 drugs in development for Retinal Degeneration by 63 companies/universities/institutes. The top development phase for Retinal Degeneration is preclinical, with 40 drugs in that stage.
How AI is Changing the Conversation Around Hospital Denials
Tanya Sanderson, RN, BSN, MBA, MHA, CLNC, Sr. Director of Revenue Integrity at XSOLIS Of the many complexities within the healthcare industry, medical necessity determinations